Singapore markets closed

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
62.36+0.55 (+0.89%)
At close: 04:00PM EDT
62.55 +0.19 (+0.30%)
After hours: 07:55PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 78.81B
Enterprise value 99.69B
Trailing P/E 17.55
Forward P/E 9.71
PEG Ratio (5 yr expected) 0.54
Price/sales (ttm)2.89
Price/book (mrq)3.95
Enterprise value/revenue 3.63
Enterprise value/EBITDA 11.14

Trading information

Stock price history

Beta (5Y monthly) 0.38
52-week change 3-8.84%
S&P500 52-week change 3-11.93%
52-week high 374.12
52-week low 357.17
50-day moving average 362.03
200-day moving average 365.27

Share statistics

Avg vol (3-month) 38.06M
Avg vol (10-day) 37.83M
Shares outstanding 51.25B
Implied shares outstanding 6N/A
Float 81.25B
% held by insiders 10.06%
% held by institutions 182.06%
Shares short (14 Jun 2022) 415.65M
Short ratio (14 Jun 2022) 42.07
Short % of float (14 Jun 2022) 41.25%
Short % of shares outstanding (14 Jun 2022) 41.25%
Shares short (prior month 12 May 2022) 416.85M

Dividends & splits

Forward annual dividend rate 42.92
Forward annual dividend yield 44.68%
Trailing annual dividend rate 32.86
Trailing annual dividend yield 34.63%
5-year average dividend yield 43.65
Payout ratio 479.89%
Dividend date 328 Jun 2022
Ex-dividend date 413 Jun 2022
Last split factor 22:1
Last split date 327 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 16.43%
Operating margin (ttm)40.50%

Management effectiveness

Return on assets (ttm)10.65%
Return on equity (ttm)23.10%

Income statement

Revenue (ttm)27.47B
Revenue per share (ttm)21.88
Quarterly revenue growth (yoy)2.60%
Gross profit (ttm)21.78B
Net income avi to common (ttm)4.51B
Diluted EPS (ttm)3.58
Quarterly earnings growth (yoy)-98.90%

Balance sheet

Total cash (mrq)6.02B
Total cash per share (mrq)4.8
Total debt (mrq)26.21B
Total debt/equity (mrq)131.60
Current ratio (mrq)1.48
Book value per share (mrq)15.88

Cash flow statement

Operating cash flow (ttm)10.61B
Levered free cash flow (ttm)8.7B